Literature DB >> 33732543

Analyzing clinical characteristics of patients with different cumulative hemodialysis durations: a cross-sectional study.

Xu Chen1, Li Yuan1, Yuan Zhang1, Houyong Dai1, Yaping Fan1, Xiaolan Chen1.   

Abstract

BACKGROUND: The objective of this study was to examine the clinical characteristics of patients with different cumulative hemodialysis (HD) durations, so as to improve their survival rate.
METHODS: In this cross-sectional study, we extracted background information and relevant clinical data from 145 patients who were undergoing maintenance HD three times a week at the Affiliated Hospital of Nantong University between January 1998 and January 2019. The study subjects were divided into four groups according to the duration of their HD: <5 years, 5-10 years, 10-15 years, and >15 years of HD. We collected the medical history and relevant clinical parameters for each subject, and measured the urea reduction ratio (URR), hemoglobin (Hb), serum calcium, phosphorus, parathyroid hormone (iPTH), and serum albumin (ALB) levels for each group.
RESULTS: The average patient age was 52.06 ±  11.93 years old. The average patient age in the 10-15 years and >15 years groups was significantly lower than in the <5 years and 5-10 years groups (P = 0.002, P < 0.001, P = 0.012, and P = 0.0025, respectively). The most common cause of end-stage renal disease (ESRD) was chronic glomerulonephritis. We found no significant differences in URR, Hb, serum calcium, serum phosphorus, iPTH, and ALB levels.
CONCLUSION: A prolonged HD duration was related to a younger mean age at the start of HD treatment. The leading cause of ESRD was chronic glomerulonephritis. We predominantly found diabetic nephropathy in the group with a duration of <5 years cumulative HD. Most of the indexes related to hemodialysis almost satisfied the recommended values in these patients. ©2021 Chen et al.

Entities:  

Keywords:  Age of onset; Anemia; Clinical characteristics; Hemodialysis; Kidney failure; Serum albumin

Year:  2021        PMID: 33732543      PMCID: PMC7953870          DOI: 10.7717/peerj.10852

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  28 in total

Review 1.  KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.

Authors: 
Journal:  Am J Kidney Dis       Date:  2015-11       Impact factor: 8.860

2.  Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?

Authors:  Johanna T Dwyer; Brett Larive; June Leung; Michael V Rocco; Tom Greene; Jerrilynn Burrowes; Glenn M Chertow; David B Cockram; W Cameron Chumlea; John Daugirdas; Anne Frydrych; John W Kusek
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

Review 3.  Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis.

Authors:  Lijie Ma; Sumei Zhao
Journal:  Int J Cardiol       Date:  2017-02-22       Impact factor: 4.164

4.  Diet quality in patients with end-stage kidney disease undergoing dialysis.

Authors:  Lauren A Roach; Kelly Lambert; Jane L Holt; Barbara J Meyer
Journal:  J Ren Care       Date:  2017-09-24

Review 5.  Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.

Authors:  Yelena Slinin; Nancy Greer; Areef Ishani; Roderick MacDonald; Carin Olson; Indulis Rutks; Timothy J Wilt
Journal:  Am J Kidney Dis       Date:  2015-11       Impact factor: 8.860

Review 6.  Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients.

Authors:  Motoko Tanaka; Hirotaka Komaba; Masafumi Fukagawa
Journal:  Ther Apher Dial       Date:  2018-05-16       Impact factor: 1.762

7.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Authors:  Geoffrey A Block; Preston S Klassen; J Michael Lazarus; Norma Ofsthun; Edmund G Lowrie; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

8.  Characteristics of patients on hemodialysis therapy for more than 30 years.

Authors:  Shigeru Otsubo; Kimiko Otsubo; Hisayuki Sugimoto; Syuitsu Ueda; Yuriko Otsubo; Osamu Otsubo; Aiji Yajima; Shigeru Yagi; Hiroshi Kataoka; Tomihito Iwasaki; Yuko Iwasa; Masaki Takahashi; Asuka Aoki; Jun Ino; Keiko Uchida; Wako Yumura; Takashi Akiba; Kosaku Nitta
Journal:  Ther Apher Dial       Date:  2007-08       Impact factor: 1.762

Review 9.  Evolving importance of kidney disease: from subspecialty to global health burden.

Authors:  Kai-Uwe Eckardt; Josef Coresh; Olivier Devuyst; Richard J Johnson; Anna Köttgen; Andrew S Levey; Adeera Levin
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

Review 10.  Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.

Authors:  Ashraf Mikhail; Christopher Brown; Jennifer Ann Williams; Vinod Mathrani; Rajesh Shrivastava; Jonathan Evans; Hayleigh Isaac; Sunil Bhandari
Journal:  BMC Nephrol       Date:  2017-11-30       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.